Medtronic Initiates Overnight Artificial Pancreas System Study In US
Medical technology provider Medtronic has begun patient enrollments in the US Overnight Closed Loop Study, a key feasibility trial aimed at commercialising a third-generation fully automated artificial pancreas system for diabetes patients. Under an investigational device exemption granted by the US Food and Drug Administration, the in-clinic study will evaluate a closed loop algorithm that…